The H2-antagonists including Cimetidine, Famotidine, and Nizatidine are facing supply disruption. Latest update on the supply of these products is given below…
| Product | Supplier | Current Stock Position | Anticipated Resupply date | Detail |
| Famotidine 20mg tablets | Tilomed Laboratories | Limited supplies | Early December 2020 | Unlicensed supplies have been sourced |
| Teva UK | Out of stock | Mid November 2020 | ||
| Famotidine 40mg tablets | Tilomed Laboratories | In stock | N/A | |
| Teva UK | Limited supplies | End November 2020 | ||
| Cimetidine 200mg tablets | Ennogen Pharma | Out of stock | June 2021 | Unlicensed supplies have been sourced |
| Medreich | Out of stock | to be confirmed | ||
| Cimetidine 400mg tablets | Ennogen Pharma | Out of stock | June 2021 | |
| Medreich | Out of stock | to be confirmed | ||
| Cimetidine 800mg tablets | Ennogen Pharma | Out of stock | June 2021 | |
| Medreich | Out of stock | to be confirmed | ||
| Cimetidine 200mg/5ml oral solution | Rosemont Pharmaceuticals | In stock | n/a | |
| Nizatidine 150mg tablets | Mylan | Out of stock | Early January 2021 | Unlicensed supplies have been sourced |
| Medreich | Out of stock | to be confirmed | ||
| Relonchem | Out of stock | End November 2020 | ||
| Nizatidine 300mg tablets | Mylan | Out of stock | Early January 2021 | Unlicensed supplies of Nizatidine 150mg capsules have been sourced |
| Medreich | Out of stock | to be confirmed | ||
| Relonchem | Out of stock | In stock |
Alium Medical, Mawdsley’s Unlicensed, Durbin PLC, and Target Healthcare have confirmed that they can source unlicensed Cimetidine 200mg, 400mg, and 800mg tablets. The three drug manufacturers have also assured that they can supply Famotidine tablets 20mg and 40mg
Ennogen and UL Global will be able to supply Cimetidine 200mg, 400mg and famotidine 20mg and 40mg tablets respectively to avert any severe scarcity of the medicines.
Mawdsley’s Unlicensed and Target Healthcare have confirmed that they can source unlicensed Nizatidine capsules.
There is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems so an EPS prescription for unlicensed Cimetidine tablets cannot be issued.
If a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘Cimetidine (strength) tablets (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special.
